Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONYThomas Chatzikonstantinou, Elżbieta Kalicińska, Thérèse Aurran‐Schleinitz et al.|EClinicalMedicine|2023Cited by 21
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor modelStefano Molica, Francesca Romana Mauro, Diana Giannarelli et al.|American Journal of Hematology|2022Cited by 10
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLLThomas Chatzikonstantinou, Thomas Longval, Lydia Scarfò et al.|HemaSphere|2024Cited by 2
Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLLThomas Chatzikonstantinou, Robert J. Kreitman, Lydia Scarfò et al.|Blood|2021Cited by 1
S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY.Thomas Chatzikonstantinou, Arnon P. Kater, Lydia Scarfò et al.|HemaSphere|2023Cited by 0